Detalles de la búsqueda
1.
Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial.
Ann Oncol
; 26(6): 1254-1262, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25862439
2.
Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients.
Ann Oncol
; 26(3): 510-6, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25471333
3.
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.
Breast Cancer Res Treat
; 149(3): 587-96, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25616355
4.
Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy.
Br J Cancer
; 111(5): 1004-13, 2014 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-24918820
5.
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer.
Br J Cancer
; 111(12): 2242-7, 2014 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25314051
6.
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG.
Ann Oncol
; 25(3): 599-605, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24504445
7.
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial.
Br J Cancer
; 109(9): 2453-61, 2013 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-24091623
8.
Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis.
Ann Oncol
; 24(8): 2029-35, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23576707
9.
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands.
Ann Oncol
; 24(8): 2036-42, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23543211
10.
CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial.
Breast Cancer Res Treat
; 140(2): 363-73, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23842856
11.
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients.
Ann Oncol
; 23(12): 3091-3097, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22865782
12.
Relevant impact of central pathology review on nodal classification in individual breast cancer patients.
Ann Oncol
; 23(10): 2561-2566, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22495317
13.
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study.
Breast Cancer Res Treat
; 134(1): 267-76, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22453754
14.
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
Psychooncology
; 21(5): 479-87, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21351188
15.
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients.
Ann Oncol
; 22(6): 1346-1352, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21228333
16.
The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer.
Br J Cancer
; 103(6): 765-71, 2010 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-20700120
17.
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
Ann Oncol
; 21(5): 974-82, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19875752
18.
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries.
Br J Surg
; 97(5): 671-9, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20393978
19.
The Distress Thermometer assessed in women at risk of developing hereditary breast cancer.
Psychooncology
; 18(10): 1080-7, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19189274
20.
Outcomes of first-line chemotherapy in patients with advanced or metastatic leiomyosarcoma of uterine and non-uterine origin.
Sarcoma
; 2009: 348910, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-20066161